Phase II study of ABVd therapy for newly diagnosed clinical stage II–IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305)

Michinori Ogura; Kuniaki Itoh; Tomohiro Kinoshita; Haruhiko Fukuda; Takeaki Takenaka; Tomoko Ohtsu; Yoshitoyo Kagami; Kensei Tobinai; Masataka Okamoto; Hideki Asaoku; Tsuneo Sasaki; Chikara Mikuni; Masami Hirano; Takaaki Chou; Kazunori Ohnishi; Hitoshi Ohno; Kaori Nasu; Kenichi Okabe; Shuichi Ikeda; Shigeo Nakamura; Tomomitsu Hotta; Masanori Shimoyama

doi:10.1007/s12185-010-0712-8

Phase II study of ABVd therapy for newly diagnosed clinical stage II–IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305)

International Journal of Hematology ◽

10.1007/s12185-010-0712-8 ◽

2010 ◽

Vol 92 (5) ◽

pp. 713-724 ◽

Cited By ~ 13

Author(s):

Michinori Ogura ◽

Kuniaki Itoh ◽

Tomohiro Kinoshita ◽

Haruhiko Fukuda ◽

Takeaki Takenaka ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Clinical Stage ◽

Stage Ii ◽

Newly Diagnosed ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study

Download Full-text

Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705)

Leukemia & Lymphoma ◽

10.3109/10428194.2012.705000 ◽

2012 ◽

Vol 54 (1) ◽

pp. 46-52 ◽

Cited By ~ 4

Author(s):

Michinori Ogura ◽

Kuniaki Itoh ◽

Kenichi Ishizawa ◽

Yukio Kobayashi ◽

Kensei Tobinai ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Stage ◽

Newly Diagnosed ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study

Download Full-text

Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508

International Journal of Hematology ◽

10.1007/s12185-012-1101-2 ◽

2012 ◽

Vol 96 (1) ◽

pp. 74-83 ◽

Cited By ~ 3

Author(s):

Yoshitoyo Kagami ◽

◽

Kuniaki Itoh ◽

Kensei Tobinai ◽

Haruhiko Fukuda ◽

...

Keyword(s):

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Hodgkin's Lymphoma ◽

Intermediate Risk ◽

Newly Diagnosed ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Chop Therapy

Download Full-text

Phase II Study of Laparoscopy-assisted Distal Gastrectomy with Nodal Dissection for Clinical Stage I Gastric Cancer: Japan Clinical Oncology Group Study JCOG0703

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyn055 ◽

2008 ◽

Vol 38 (7) ◽

pp. 501-503 ◽

Cited By ~ 21

Author(s):

Y. Kurokawa ◽

H. Katai ◽

H. Fukuda ◽

M. Sasako ◽

Keyword(s):

Gastric Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Distal Gastrectomy ◽

Phase Ii Study ◽

Clinical Stage ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Nodal Dissection

Download Full-text

A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients: Japan Clinical Oncology Group Study JCOG9203

International Journal of Hematology ◽

10.1532/ijh97.05084 ◽

2006 ◽

Vol 83 (1) ◽

pp. 55-62 ◽

Cited By ~ 5

Author(s):

Fumi Mizoroki ◽

Yuko Hirose ◽

Masayuki Sano ◽

Haruhiko Fukuda ◽

Kensei Tobinai ◽

...

Keyword(s):

Elderly Patients ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Aggressive Lymphoma ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study

Download Full-text

Phase II Study of Oral Etoposide and Intravenous Irinotecan for Patients with Platinum-resistant and Taxane-pretreated Ovarian Cancer: Japan Clinical Oncology Group Study 0503

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyr201 ◽

2012 ◽

Vol 42 (3) ◽

pp. 222-225 ◽

Cited By ~ 3

Author(s):

K. Matsumoto ◽

N. Katsumata ◽

I. Saito ◽

T. Shibata ◽

I. Konishi ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oral Etoposide ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Platinum Resistant

Download Full-text

Phase II study of rituximab plus high-dose ara-C (HDAC)-containing chemotherapy (CTX) followed by ASCT in untreated mantle cell lymphoma (MCL): Japan Clinical Oncology Group study (JCOG0406).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8565 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8565-8565

Author(s):

Michinori Ogura ◽

Kensei Tobinai ◽

Taro Shibata ◽

Kiyoshi Ando ◽

Mitsutoshi Kurosawa ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

High Dose ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Mantle Cell

Download Full-text

A Phase II Study of Doxifluridine in Elderly Patients with Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG 9410)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyf022 ◽

2002 ◽

Vol 32 (3) ◽

pp. 90-94 ◽

Cited By ~ 8

Author(s):

N. Ikeda

Keyword(s):

Gastric Cancer ◽

Elderly Patients ◽

Advanced Gastric Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study

Download Full-text

Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505

Annals of Oncology ◽

10.1093/annonc/mdf287 ◽

2002 ◽

Vol 13 (9) ◽

pp. 1347-1355 ◽

Cited By ~ 40

Author(s):

K. Itoh ◽

T. Ohtsu ◽

H. Fukuda ◽

Y. Sasaki ◽

M. Ogura ◽

...

Keyword(s):

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Hodgkin's Lymphoma ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Randomized Phase Ii ◽

Non Hodgkin's Lymphoma ◽

Prophylactic Use

Download Full-text

Phase II Study of Amrubicin in Patients with Refractory or Resistant Relapsed Small-Cell Lung Cancer: Japan Clinical Oncology Group Study (JCOG0901)

Annals of Oncology ◽

10.1093/annonc/mds415 ◽

2012 ◽

Vol 23 ◽

pp. ix492 ◽

Cited By ~ 2

Author(s):

H. Daga ◽

H. Murakami ◽

N. Yamamoto ◽

T. Shibata ◽

M. Endo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Japan Clinical Oncology Group ◽

Oncology Group Study

Download Full-text

A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyp078 ◽

2009 ◽

Vol 39 (10) ◽

pp. 686-689 ◽

Cited By ~ 37

Author(s):

Y. Kurokawa ◽

M. Muto ◽

K. Minashi ◽

N. Boku ◽

H. Fukuda ◽

...

Keyword(s):

Esophageal Carcinoma ◽

Clinical Oncology ◽

Endoscopic Mucosal Resection ◽

Phase Ii ◽

Phase Ii Trial ◽

Clinical Stage ◽

Combined Treatment ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study

Download Full-text